{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:31:44Z","timestamp":1761154304610},"reference-count":90,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1053\/beog.2001.0239","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"937-952","source":"Crossref","is-referenced-by-count":22,"title":["Gastrointestinal disease"],"prefix":"10.1053","volume":"15","author":[{"given":"Catherine","family":"Williamson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beog.2001.0239_RF1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1471-0528.1977.tb12619.x","article-title":"Pregnancy heartburn in Nigerians and Caucasians with theories about aetiology based on manometric recordings from the oesophagus and stomach","volume":"84","author":"Bassey","year":"1977","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2001.0239_RF2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0028-2243(95)02069-1","article-title":"Upper gastrointestinal symptoms in the third trimester of the normal pregnancy","volume":"60","author":"Knudsen","year":"1995","journal-title":"European Journal of Obstetrics, Gynecology and Reproductive Biology"},{"key":"10.1053\/beog.2001.0239_RF3","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1440-1746.1998.tb00564.x","article-title":"Symptomatic gastro-oesophageal reflux in pregnancy: a prospective study among Singaporean women","volume":"13","author":"Ho","year":"1998","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/beog.2001.0239_RF4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1471-0528.1992.tb13873.x","article-title":"Determinants of pregnancy heartburn","volume":"99","author":"Marrero","year":"1992","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2001.0239_RF5","first-page":"912","article-title":"The use of gastrointestinal drugs during pregnancy and lactation","volume":"80","author":"Lewis","year":"1985","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/beog.2001.0239_RF6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmj.1.5748.523","article-title":"Associations between drugs administered during pregnancy and congenital abnormalities of the fetus","volume":"1","author":"Nelson","year":"1971","journal-title":"British Medical Journal"},{"key":"10.1053\/beog.2001.0239_RF7","first-page":"569","article-title":"Heartburn and regurgitation in pregnancy. Efficacy and innocuousness of treatment with Gaviscon suspension","volume":"83","author":"Uzan","year":"1988","journal-title":"Revue Francaise de Gynecologie et d'Obstetrique"},{"key":"10.1053\/beog.2001.0239_RF8","series-title":"Prescribing in Pregnancy 2000","article-title":"Treatment of common minor and self-limiting conditions","author":"Avery","year":"2000"},{"key":"10.1053\/beog.2001.0239_RF9","series-title":"Medical Disorders in Obstetric Practice","article-title":"Disorders of the liver, biliary system and pancreas","author":"Fagan","year":"1995"},{"key":"10.1053\/beog.2001.0239_RF10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2036.1987.tb00616.x","article-title":"Review: post-marketing surveillance of the safety of cimetidine\u2014the problems of data interpretation","volume":"1","author":"Jones","year":"1987","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/beog.2001.0239_RF11","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/BF02088230","article-title":"Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study","volume":"41","author":"Magee","year":"1996","journal-title":"Digestive Diseases Science"},{"key":"10.1053\/beog.2001.0239_RF12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1471-0528.1998.tb10233.x","article-title":"Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole","volume":"105","author":"Kallen","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2001.0239_RF13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0002-9378(98)70072-9","article-title":"The safety of omeprazole during pregnancy: a multicenter prospective controlled study","volume":"179","author":"Lalkin","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/oxfordjournals.aje.a010036","article-title":"Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes","volume":"150","author":"Ruigomez","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1053\/beog.2001.0239_RF15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-2115(00)00388-2","article-title":"Use of omeprazole during pregnancy\u2014no hazard demonstrated in 955 infants exposed during pregnancy","volume":"96","author":"Kallen","year":"2001","journal-title":"European Journal of Obstetrics, Gynecology and Reproductive Biology"},{"key":"10.1053\/beog.2001.0239_RF16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1159\/000007570","article-title":"Omeprazole for peptic ulcer disease in pregnancy","volume":"59","author":"Brunner","year":"1998","journal-title":"Digestion"},{"key":"10.1053\/beog.2001.0239_RF17","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1023\/A:1018898707449","article-title":"Cisapride use during human pregnancy: a prospective, controlled multicenter study","volume":"42","author":"Bailey","year":"1997","journal-title":"Digestive Diseases Science"},{"key":"10.1053\/beog.2001.0239_RF18","first-page":"605","article-title":"Hyperemesis gravidarum. A review","volume":"39","author":"Hod","year":"1994","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1053\/beog.2001.0239_RF19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0957-5847(97)80092-3","article-title":"Hyperemesis gravidarum","volume":"7","author":"Nelson-Piercy","year":"1997","journal-title":"Current Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2001.0239_RF20","series-title":"Handbook of Obstetric Medicine","author":"Nelson-Piercy","year":"1997"},{"key":"10.1053\/beog.2001.0239_RF21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1068-607X(98)00110-3","article-title":"Home subcutaneous metochlopramide therapy for hyperemesis gravidarum","volume":"5","author":"Buttino","year":"1998","journal-title":"Primary Care Update for Ob-Gyns"},{"key":"10.1053\/beog.2001.0239_RF22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.jp.7200398","article-title":"Home subcutaneous metoclopramide therapy for hyperemesis gravidarum","volume":"20","author":"Buttino","year":"2000","journal-title":"Journal of Perinatology"},{"key":"10.1053\/beog.2001.0239_RF23","first-page":"245","article-title":"An evaluation of the teratogenicity of certain antinauseant drugs","volume":"125","author":"Milkovich","year":"1975","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00003495-200059040-00005","article-title":"A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy","volume":"59","author":"Mazzotta","year":"2000","journal-title":"Drugs"},{"key":"10.1053\/beog.2001.0239_RF25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0002-9378(16)32338-9","article-title":"Bendectin and fetal development. A study of Boston City Hospital","volume":"142","author":"Morelock","year":"1982","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF26","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0002-9378(96)70213-2","article-title":"Droperidol and diphenhydramine in the management of hyperemesis gravidarum","volume":"174","author":"Nageotte","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1471-0528.1994.tb13053.x","article-title":"Corticosteroids for the treatment of hyperemesis gravidarum","volume":"101","author":"Nelson-Piercy","year":"1994","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2001.0239_RF28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/qjmed\/89.2.103","article-title":"Successful management of hyperemesis gravidarum using steroid therapy","volume":"89","author":"Taylor","year":"1996","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1053\/beog.2001.0239_RF29","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0002-9378(98)70547-2","article-title":"Experience with oral methylprednisolone in the treatment of refractory hyperemesis gravidarum","volume":"178","author":"Safari","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1471-0528.1996.tb09779.x","article-title":"An N-of-1 trial for treatment of hyperemesis gravidarum","volume":"103","author":"Magee","year":"1996","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2001.0239_RF31","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0002-9378(98)70189-9","article-title":"The efficacy of methylprednisolone in the treatment of hyperemesis gravidarum: a randomized, double-blind, controlled study","volume":"179","author":"Safari","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-5456(00)00017-6","article-title":"Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum","volume":"108","author":"Nelson-Piercy","year":"2001","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2001.0239_RF33","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/pgmj.72.853.688","article-title":"Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran)","volume":"72","author":"Tincello","year":"1996","journal-title":"Postgraduate Medical Journal"},{"key":"10.1053\/beog.2001.0239_RF34","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0140-6736(92)92923-4","article-title":"Ondansetron and hyperemesis gravidarum","volume":"340","author":"Guikontes","year":"1992","journal-title":"Lancet"},{"key":"10.1053\/beog.2001.0239_RF35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0140-6736(93)90054-K","article-title":"Ondansetron and hyperemesis gravidarum","volume":"341","author":"World","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/beog.2001.0239_RF36","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0002-9378(96)70607-5","article-title":"A pilot study of intravenous ondansetron for hyperemesis gravidarum","volume":"174","author":"Sullivan","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0028-2243(91)90202-V","article-title":"Ginger treatment of hyperemesis gravidarum","volume":"38","author":"Fischer-Rasmussen","year":"1991","journal-title":"European Journal of Obstetrics, Gynecology and Reproductive Biology"},{"key":"10.1053\/beog.2001.0239_RF38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0261-5614(98)80008-3","article-title":"Enteral nutrition by percutaneous endoscopic gastrojejunostomy in severe hyperemesis gravidarum: a report of two cases","volume":"17","author":"Serrano","year":"1998","journal-title":"Clinical Nutrition"},{"key":"10.1053\/beog.2001.0239_RF39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/0148607198022004238","article-title":"Percutaneous endoscopic gastrostomy for nutrition support in pregnancy associated with hyperemesis gravidarum and anorexia nervosa","volume":"22","author":"Godil","year":"1998","journal-title":"Journal of Parenteral and Enteral Nutrition"},{"key":"10.1053\/beog.2001.0239_RF40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0029-7844(96)00174-3","article-title":"Nasogastric enteral feeding in the management of hyperemesis gravidarum","volume":"88","author":"Hsu","year":"1996","journal-title":"Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF41","first-page":"29","article-title":"Parenteral nutrition in hyperemesis gravidarum","volume":"9","author":"Charlin","year":"1993","journal-title":"Nutrition"},{"key":"10.1053\/beog.2001.0239_RF42","first-page":"164","article-title":"Pregnancy outcome in patients requiring parenteral nutrition","volume":"8","author":"Russo-Stieglitz","year":"1999","journal-title":"Journal of Maternal and Fetal Medicine"},{"key":"10.1053\/beog.2001.0239_RF43","first-page":"831","article-title":"Use of the peripherally inserted central catheter for parenteral nutrition during pregnancy","volume":"81","author":"Greenspoon","year":"1993","journal-title":"Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF44","first-page":"265","article-title":"The course of inflammatory bowel disease during pregnancy and postpartum","volume":"75","author":"Mogadam","year":"1981","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/beog.2001.0239_RF45","first-page":"211","article-title":"The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome","volume":"6","author":"Baiocco","year":"1984","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1053\/beog.2001.0239_RF46","first-page":"1595","article-title":"Crohn's disease as a risk factor for the outcome of pregnancy","volume":"47","author":"Morales","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/beog.2001.0239_RF47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0016-5085(81)90193-1","article-title":"Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome","volume":"80","author":"Mogadam","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1053\/beog.2001.0239_RF48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0016-5085(98)70628-6","article-title":"The safety of mesalamine in human pregnancy: a prospective controlled cohort study","volume":"114","author":"Diav-Citrin","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/beog.2001.0239_RF49","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(94)92009-5","article-title":"Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine?","volume":"344","author":"Colombel","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/beog.2001.0239_RF50","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1365-2036.1998.00417.x","article-title":"Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules","volume":"12","author":"Marteau","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/beog.2001.0239_RF51","first-page":"2201","article-title":"Safety of topical 5-aminosalicylic acid in pregnancy","volume":"92","author":"Bell","year":"1997","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/beog.2001.0239_RF52","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/00016349409006251","article-title":"Disposition of 5-aminosalicylic acid and N -acetyl-5-aminosalicylic acid in fetal and maternal body fluids during treatment with different 5-aminosalicylic acid preparations","volume":"73","author":"Christensen","year":"1994","journal-title":"Acta Obstetrica et Gynecologica Scandinavica"},{"key":"10.1053\/beog.2001.0239_RF53","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinte.160.5.610","article-title":"The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy and lactation","volume":"160","author":"Janssen","year":"2000","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/beog.2001.0239_RF54","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0016-5085(90)91027-4","article-title":"Safety of azathioprine in pregnancy in inflammatory bowel disease","volume":"99","author":"Alstead","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/beog.2001.0239_RF55","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-111-8-641","article-title":"6-mercaptopurine in the management of inflammatory bowel disease: short and long-term toxicity","volume":"111","author":"Present","year":"1989","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/beog.2001.0239_RF56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9378(95)90567-7","article-title":"Safety of metronidazole in pregnancy: a meta-analysis","volume":"172","author":"Burtin","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2125.1997.00660.x","article-title":"Is metronidazole teratogenic? A meta-analysis","volume":"44","author":"Caro-Paton","year":"1997","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1053\/beog.2001.0239_RF58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1155\/2000\/957649","article-title":"Prospective, controlled multicentre study of loperamide in pregnancy","volume":"14","author":"Einarson","year":"2000","journal-title":"Canadian Journal of Gastroenterology"},{"key":"10.1053\/beog.2001.0239_RF59","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/bmj.1.6014.870","article-title":"Fetal complications of obstetric cholestasis","volume":"1","author":"Reid","year":"1976","journal-title":"British Medical Journal"},{"key":"10.1053\/beog.2001.0239_RF60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.1840020114","article-title":"The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile","volume":"2","author":"Reyes","year":"1982","journal-title":"Hepatology"},{"key":"10.1053\/beog.2001.0239_RF61","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1471-0528.1988.tb06791.x","article-title":"Fetal outcome in obstetric cholestasis","volume":"95","author":"Fisk","year":"1988","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2001.0239_RF62","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0002-9378(94)70304-3","article-title":"Intrahepatic cholestasis of pregnancy: a retrospective case\u2013control study of perinatal outcome","volume":"170","author":"Rioseco","year":"1994","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF63","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0168-8278(95)80261-4","article-title":"Serum conjugated bile acid profile during intrahepatic cholestasis of pregnancy","volume":"22","author":"Bacq","year":"1995","journal-title":"Journal of Hepatology"},{"key":"10.1053\/beog.2001.0239_RF64","first-page":"941","article-title":"Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. A retrospective study of 19 cases","volume":"79","author":"Berkane","year":"2000","journal-title":"Acta Obstetsica et Gynecologica Scandinavica"},{"key":"10.1053\/beog.2001.0239_RF65","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0168-8278(98)80207-9","article-title":"Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy","volume":"28","author":"Brites","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1053\/beog.2001.0239_RF66","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/gut.37.4.580","article-title":"Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid","volume":"37","author":"Davies","year":"1995","journal-title":"Gut"},{"key":"10.1053\/beog.2001.0239_RF67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0301-2115(96)02442-6","article-title":"S-adenosyl methionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial","volume":"67","author":"Floreani","year":"1996","journal-title":"European Journal of Obstetrics, Gynecology and Reproductive Biology"},{"key":"10.1053\/beog.2001.0239_RF68","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/0140-6736(91)92415-X","article-title":"Management of intrahepatic cholestasis in pregnancy","volume":"338","author":"Mazzella","year":"1991","journal-title":"Lancet"},{"key":"10.1053\/beog.2001.0239_RF69","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/jhep.2001.22647","article-title":"Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers","volume":"33","author":"Mazzella","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/beog.2001.0239_RF70","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1471-0528.1998.tb09976.x","article-title":"A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy","volume":"105","author":"Nicastri","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2001.0239_RF71","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/hep.1840150612","article-title":"Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy","volume":"15","author":"Palma","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/beog.2001.0239_RF72","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0168-8278(97)80146-8","article-title":"Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo","volume":"27","author":"Palma","year":"1997","journal-title":"Journal of Hepatology"},{"key":"10.1053\/beog.2001.0239_RF73","first-page":"60","article-title":"Amniotic fluid bile acids in normal and pathologic pregnancy","volume":"56","author":"Heikkinen","year":"1980","journal-title":"Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF74","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0002-9378(75)90727-9","article-title":"Fetal bile acid levels in pregnancies complicated by maternal intrahepatic cholestasis","volume":"122","author":"Laatikainen","year":"1975","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF75","first-page":"313","article-title":"Serum bile acids in cholestasis of pregnancy","volume":"50","author":"Laatikainen","year":"1977","journal-title":"Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF76","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0168-8278(98)80255-9","article-title":"Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy","volume":"29","author":"Brites","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1053\/beog.2001.0239_RF77","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1471-0528.1992.tb14465.x","article-title":"The treatment of intrahepatic cholestasis of pregnancy by dexamethasone","volume":"99","author":"Hirvioja","year":"1992","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2001.0239_RF78","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1479-828X.1994.tb02695.x","article-title":"Intrahepatic cholestasis of pregnancy, worsening after dexamethasone","volume":"34","author":"Kretowicz","year":"1994","journal-title":"Australia and New Zealand Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2001.0239_RF79","first-page":"122","article-title":"S -adenosyl methionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial","volume":"37","author":"Frezza","year":"1990","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/beog.2001.0239_RF80","first-page":"1084","article-title":"S -adenosyl- L -methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results","volume":"13","author":"Ribalta","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/beog.2001.0239_RF81","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0028-2243(82)90090-9","article-title":"Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine","volume":"14","author":"Heikkinen","year":"1982","journal-title":"European Journal of Obstetrics, Gynecology and Reproductive Biology"},{"key":"10.1053\/beog.2001.0239_RF82","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9378(78)90743-3","article-title":"Effect of cholestyramine and phenobarbital on pruritus and serum bile acid levels in cholestasis of pregnancy","volume":"132","author":"Laatikainen","year":"1978","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2001.0239_RF83","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1471-0528.1995.tb09077.x","article-title":"Severe fetal intracranial haemorrhage during treatment with cholestyramine for intrahepatic cholestasis of pregnancy","volume":"102","author":"Sadler","year":"1995","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2001.0239_RF84","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2362.1998.00282.x","article-title":"Oral guar gum treatment of intrahepatic cholestasis and pruritus in pregnant women: effects on serum cholestanol and other non-cholesterol sterols","volume":"28","author":"Gylling","year":"1998","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1053\/beog.2001.0239_RF85","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/j.1600-0412.2000.079004260.x","article-title":"Oral guar gum, a gel-forming dietary fiber relieves pruritus in intrahepatic cholestasis of pregnancy","volume":"79","author":"Riikonen","year":"2000","journal-title":"Acta Obstetrica et Gynecologica Scandinavica"},{"key":"10.1053\/beog.2001.0239_RF86","first-page":"217","article-title":"Diagnosis and therapy of blood coagulation disorders in intrahepatic cholestasis","volume":"98","author":"Herre","year":"1976","journal-title":"Zentralbl Gynakol"},{"key":"10.1053\/beog.2001.0239_RF87","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1515\/JPM.2000.047","article-title":"Administration of interferon-\u03b1 during pregnancy: effects on fetus","volume":"28","author":"Hiratsuka","year":"2000","journal-title":"Journal of Perinatal Medicine"},{"key":"10.1053\/beog.2001.0239_RF88","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00004836-200101000-00017","article-title":"Conception and pregnancy during interferon-alpha therapy for chronic hepatitis C","volume":"32","author":"Trotter","year":"2001","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1053\/beog.2001.0239_RF89","first-page":"1040","article-title":"Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viraemic chronic hepatitis B patients","volume":"32","author":"van Nunen","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1053\/beog.2001.0239_RF90","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00006254-199907000-00026","article-title":"Herpes simplex hepatitis in pregnancy: a case report and review of the literature","volume":"54","author":"Kang","year":"1999","journal-title":"Obstetric and Gynecological Survey"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693401902391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693401902391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T21:15:51Z","timestamp":1581023751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693401902391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S1521693401902391"],"URL":"https:\/\/doi.org\/10.1053\/beog.2001.0239","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}